Dr. Sandesh Dewan, MD
Internal Medicine (Internal Medicine Physician)
- Medicare participating
At a glance
- Years since graduation
- 8
- In the NPI registry since
- 2019
- Medicare patients seen, 2024
- 18
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
NM license MD2024-0513
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Presbyterian Hospital Albuquerque, NM
Medical groups
- Presbyterian Healthcare Services (1,395 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 18
- Services billed
- 28
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Albuquerque, NM | 77 |
| Hydrocortisone Other prescribers in Albuquerque, NM | 46 |
| Alendronate Sodium Other prescribers in Albuquerque, NM | 16 |
| Methimazole Other prescribers in Albuquerque, NM | 16 |
| Metformin Hcl Other prescribers in Albuquerque, NM | 13 |
| Ozempic (semaglutide) Other prescribers in Albuquerque, NM | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 28 payments worth $529 in total to this clinician.
| Amgen Inc. | $142 |
|---|---|
| Novo Nordisk Inc | $80.70 |
| Abbott Laboratories | $57.73 |
| Recordati_rare_diseases_inc. | $51.74 |
| Lilly USA, LLC | $36.93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34.82 |
| Tandem Diabetes Care, Inc. | $32.92 |
| Rgh Enterprises LLC | $22.28 |
| Food and Beverage | $529 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.